Federal Register Notice: FDA is requesting that any industry organizations interested in participating in the selection of a nonvoting industry representative to serve on CBER’s Cellular, Tissue, and Gene Therapies Advisory Committee notify FDA in writing. The agency is also requesting nominations for a nonvoting industry representative to serve on the panel. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current or upcoming vacancies effective with this notice. To view this notice, click here.